NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults27 Jul 2026
Granules India Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Granules India Limited has announced its Q1 FY27 financial results, with revenue growing 22% to INR1,477 crores, gross margin at 65.6%, EBITDA growing 37% to INR339 crores, and profit after tax growing 60% to INR180 crores. The company has also highlighted its return on capital, which has improved to 18%, and its net debt to EBITDA ratio is now 0.07x, making it debt-free for all practical purposes.
BSECompany Update▲ PositiveResults27 Jul 2026
Aelea Commodities Ltd
Intimation under Reg.30 of SEBI (LODR) Regulations, 2015 - Voluntary Disclosure of Business Update for Q1_FY2026-27.
Aelea Commodities Ltd has provided a business update for Q1 FY 2026-27, reporting revenue from operations exceeding ₹108 Crore, with a strong execution pipeline and production capacity booked up to 81% for Q2 FY27.
BSECompany Update▲ PositiveResults27 Jul 2026
Granules India Ltd-$
Transcript of the earnings call for Q1 of FY27
Granules India Ltd reported its Q1 FY27 earnings, with revenue growing 22% YoY to INR1,477 crores, gross margin at 65.6%, EBITDA growing 37% to INR339 crores, and profit after tax growing 60% to INR180 crores. The company's return on capital improved to 18% and net debt to EBITDA is 0.07x, making it debt-free for practical purposes.
NSEPress Release▲ PositiveJoint Venture27 Jul 2026
Tata Elxsi Limited
Press Release
Tata Elxsi Limited has formed a strategic partnership with Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) to accelerate healthcare innovation and medical technology development.
BSECompany Update▲ PositiveJoint Venture27 Jul 2026
Tata Elxsi Ltd
Please find enclosed the Press Release dated July 27, 2026, titled "SCTIMST and Tata Elxsi Forge Strategic Partnership to Accelerate Healthcare Innovation and Medical Technology Development".
Tata Elxsi Ltd has formed a strategic partnership with Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) to accelerate healthcare innovation and medical technology development. The partnership combines SCTIMST's clinical expertise and biomedical research with Tata Elxsi's advanced engineering capabilities to enable next-generation healthcare solutions for India and global markets.
NSEGeneral Updates▲ PositiveExpansion27 Jul 2026
Rhetan TMT Limited
General Updates
Rhetan TMT Limited has completed its 1 MW captive solar power project, achieving all regulatory and execution milestones. The project is expected to commence power generation by the end of the first week of August 2026. This initiative reflects the company's commitment to building a cost-competitive and sustainable manufacturing operation.
NSEGeneral Updates▲ PositiveExpansion27 Jul 2026
Rhetan TMT Limited
General Updates
Rhetan TMT Limited has secured BIS certification for the manufacture of premium high-strength TMT grades, making it eligible to supply to government and PSU infrastructure projects across India. This development marks the beginning of a new chapter for the company, with the potential to unlock a new addressable market and enhance its premium product mix.
BSECompany Update▲ PositiveResults27 Jul 2026
Dachepalli Publishers Ltd
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended and in terms of other applicable laws -
Q1 FY27 Investor Presentation ....
Dachepalli Publishers Ltd has released its Q1 FY27 investor presentation, highlighting a strong start to the financial year with encouraging momentum across its publishing and integrated education businesses. The company has begun to invest in strengthening its content portfolio, expanding its operational infrastructure, and enhancing its reach across schools, institutions, and channel partners. Key highlights include a 26.03% QoQ growth in total revenue, 58.76% QoQ growth in EBITDA, and 22.28% QoQ growth in PAT.
BSECompany Update▲ PositiveExpansion27 Jul 2026
Rhetan TMT Ltd
As attached
Rhetan TMT Ltd has achieved all regulatory and execution milestones for its 1 MW captive solar power project, with installation completed and power generation expected to commence by the end of the first week of August 2026. This project demonstrates the company's ability to execute strategic initiatives on schedule and marks a significant step towards sustainable, environmentally responsible steel manufacturing.
BSECompany Update▲ PositiveExpansion27 Jul 2026
Rhetan TMT Ltd
As attached
Rhetan TMT Ltd has secured BIS certification for the manufacture of high-strength TMT bars, making it eligible to supply to government and PSU infrastructure projects across India. This development strengthens the company's market positioning, widens its addressable market, and enhances its premium product mix.
BSECompany Update▲ PositivePledge27 Jul 2026
RattanIndia Power Ltd
Release of Non Disposal Undertaking (NDU) on the shares of the Company
RattanIndia Power Ltd has released its promoters' shares from a Non Disposal Undertaking (NDU) with Kotak Mahindra Bank Ltd, making the entire shareholding of the promoters free from encumbrances.
NSEInvestor Presentation▲ PositiveResults27 Jul 2026
Huhtamaki India Limited
Investor Presentation
Huhtamaki India Limited has informed the Exchange about Investor Presentation for the 2nd quarter ended June 30, 2026, with unaudited financial results showing improved net sales and strong margins.
BSECompany Update▲ PositiveResults27 Jul 2026
Huhtamaki India Ltd
Investor Presentation for the quarter ended June 30, 2026
Huhtamaki India Ltd has released its unaudited financial results for the 2nd quarter ended June 30, 2026, showing a 23.1% YoY growth in net sales, with EBITDA and EBIT higher by 55.1% and 71.8% YoY respectively. The company has delivered profitable growth through strong execution across volume, pricing, and efficiency, with improved margins and a one-time impairment charge.
BSECompany Update▲ PositiveOrder Win27 Jul 2026
Shelter Pharma Ltd
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015-Receipt of Significant International Purchase Orders.
Shelter Pharma Ltd has received significant international purchase orders from Genet International for Veterinary Feed Supplements products, valued at USD 12,285, which is expected to strengthen the company's global presence and contribute positively to its revenue growth and overall business expansion.
BSECompany Update▲ PositiveProduct Launch27 Jul 2026
Valiant Communications Ltd-$
Press Release titled "Zero-Day Attacks Mitigation - A Solution from Valiant Communications"
Valiant Communications Ltd has announced a solution to mitigate zero-day attacks, leveraging its Network Isolation Kill Switch and VCL-Network MouseTrap products, which detect and contain zero-day exploits without relying on signature-based security.
NSEInvestor Presentation▲ PositiveExpansion27 Jul 2026
Iris Clothings Limited
Investor Presentation
Iris Clothings Limited has informed the Exchange about Investor Presentation, showcasing its growth phase as a well-established listed kids' apparel brand with consumer sales of almost Rs. 300 crores, and its vision for 2030 as the biggest kidswear brand in India with 20,000+ retail touchpoints.
BSECompany Update▲ PositiveOrder Win27 Jul 2026
HRS Aluglaze Ltd
Business Update for the quarter ended on 30th June, 2026 (Q1FY27)
HRS Aluglaze Ltd reported a strong operational performance in Q1FY27, with maintained execution across ongoing façade projects, secured orders worth ₹25.5 crore, and an unexecuted order book of ₹112.3 crore as on June 30, 2026. The company's subsidiary, Geotrix Pvt. Ltd., commenced commercial operations and strengthened its business momentum. The company is also undertaking a capital expenditure programme to enhance production capacity and operational efficiencies.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults27 Jul 2026
Anthem Biosciences Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Anthem Biosciences Limited has announced its Q1 FY27 results, with consolidated revenues from operations at Rs. 418 crores, EBITDA at Rs. 176 crores, and PAT at Rs. 120 crores. The company's net cash position as of June 30, 2026, was Rs. 1,720 crores. The management has stated that the underlying demand remains strong, with a higher concentration of scheduled deliveries in the latter half of the year.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults27 Jul 2026
Mahindra Logistics Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Mahindra Logistics Limited has announced the transcript of its Q1 FY27 earnings conference call, which was held on July 21, 2026. The company's Managing Director and CEO, Hemant Sikka, and CFO, Isha Dalal, discussed the company's financial results, which showed a significant step-up in profitability and a 23% year-over-year growth in consolidated revenue.
BSECompany Update▲ PositiveResults27 Jul 2026
Mahindra Logistics Ltd
Transcript of the Earnings Conference Call of the Company for the first quarter ended 30 June 2026 held on Tuesday 21 July 2026. Detailed disclosure is enclosed.
Mahindra Logistics Ltd has announced its Q1 FY27 earnings, with a significant step-up in profitability, moving from a PAT loss of INR 10.8 crores in Q1FY26 to a PAT profit of INR 25.4 crores in Q1FY27. Consolidated revenue grew by 23% Y-o-Y, reflecting broad-based strength of its businesses.